![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Characteristics, treatment patterns, and viral load for treatment-experienced people living with HIV and switching to an MTR or STR ARV after 2018
|
|
|
EACS 2021 Oct 27-30
B. Chastek1, A. Anderson1, J. Gruber2, S. Majethia2, W. Zachry2, D. Mezzio2, A. Colson3
1Optum, Eden Prairie, United States, 2Gilead Sciences, Foster City, United States, 3Community Research Initiative (CRI), Boston, United States
![1030211](../images/103021/103021-6/1030211.gif)
![1030212](../images/103021/103021-6/1030212.gif)
![1030213](../images/103021/103021-6/1030213.gif)
![1030214](../images/103021/103021-6/1030214.gif)
![1030215](../images/103021/103021-6/1030215.gif)
![1030216](../images/103021/103021-6/1030216.gif)
![1030217](../images/103021/103021-6/1030217.gif)
![1030218](../images/103021/103021-6/1030218.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|